undamentalytics Newsletter
Sign in

Novavax Inc balance sheet

At the end of fiscal 2025, Novavax Inc had total assets of $1.18bn, total liabilities of $1.30bn and shareholders' equity of −$128m. It held $241m in cash against $244m of debt: net debt of $3.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents81417119329314410670795531,5151,337569530241191
Receivables0212820——8262455—————
Inventory———————————9374291210
Total current assets332650145188287288203119971,2482,1551,7031,1441,129978771
Goodwill33333359555352545251135131126127107113113
Total assets75671022352763863943022081731,5822,5772,2591,7971,5601,177956
Accounts payable43361312669354127217133422523
Deferred revenue (current)0—0003430261023001,40037024167514087
Total current liabilities10812183476667446265802,3902,4601,6351,154460331
Short-term debt—−0−0110———————————
Long-term debt001100316318319321322323166168170244291
Total debt001210316318319321322323491168170244291
Total liabilities1613223246934004043763599552,9282,8932,5142,1841,3041,146
Shareholders' equity595480203230293−6−102−168−186627−352−634−717−624−128−191
Net debt (negative = net cash)−8−14−16−118−31−93172211249242−231−1,192−846−400−3614100
Shares outstanding————————19m—71m76m86m—160m163m165m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: MGTX vs NVAXMNKD vs NVAXNVAX vs SVA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Novavax Inc's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Novavax Inc.